Annual Publication 2025 FINAL 05292025 accessible - Flipbook - Page 25
L-R: MARC J. KAHN, MD; JEFFERSON W. KINNEY, PHD; KATE ZHONG, MD; JEFFREY L. CUMMINGS, MD; AND MARK GUADAGNOLI, PHD
The panelists delved deeper into new
insights when it comes to Alzheimer’s
disease, such as how in昀氀ammation may
play a signi昀椀cant role in Alzheimer’s and
many other diseases and how lifestyle
changes – like implementing the six pillars
of brain health (being social, engaging
your brain, managing stress, exercising,
sleeping, and eating right) – can bene昀椀t
your brain’s health.
Overall, the transition of the department
of brain health to the school of medicine
bene昀椀ts the department’s research goals.
Dr. Kinney states, “We’ve been successful
in what we’re doing because our expertise
is complementary and not duplicative.
And that really has been our strength,
but it’s also why our move to the school
of medicine is unbelievably powerful.
Because now, there are opportunities to
interact with the strength here that we had
not had that will only expand on what we’re
doing.”
The arrival of the department also allows
the school to expand on the various
resources it can provide to the community.
that. We want to hire some more scientists
and we want to build out our clinical
services, so that we can lead this region in
the care of things, such as stroke, epilepsy,
neurocognitive disorders, and the others.”
EDITOR’S NOTE: Since the writing of
this article, the blood-based diagnostic
referenced by Dr. Kinney has received FDA
approval.
Dr. Kahn says, “We have … some worldclass researchers in cognitive disorders
and neuroscience, and what we want to
do in the school of medicine is build upon
SUMMER 2025 MAGAZINE
25